公司資料
Orgenesis 股價、新聞與催化劑
- 股票代碼:
- ORGS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.10 USD (+205.81%)
收盤價
最後更新: 2026年8月20日
—
市值
股價為何變動
Current closing-price context is not available for ORGS.
公司概覽
業務概覽
Orgenesis is a cell-therapy and advanced-manufacturing company focused on decentralized manufacturing, point-of-care cell processing, and enabling infrastructure for regenerative medicine. Its story blends therapeutic ambition with platform and services capability.
所在地與產業分類
Orgenesis is headquartered in the United States and listed on NASDAQ, with a global and platform-oriented biotech profile. It sits between cell therapy, manufacturing services, and biotech infrastructure.
商業模式特徵
The business model depends on platform partnerships, manufacturing solutions, and the ability to commercialize decentralized cell-therapy workflows. Investors watch strategic deals, platform adoption, and the company's ability to translate infrastructure into revenue.
生技產業定位
Orgenesis occupies a niche infrastructure position within biotech. It is less of a classic drug stock and more of a platform-enablement story tied to cell therapy manufacturing.
未來催化劑
- Orgenesis’ catalysts are cell-therapy manufacturing, point-of-care platform execution, and any update that clarifies how the company is monetizing its assets. The story is still mostly about platform commercialization.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。